Medications ›leuprolide mesylate

leuprolide mesylate

RxCUI 2595041 precise ingredient

Contraindicated with · 3

Diagnoses2

Pregnancy Reproduction

Condition families1

Reproductive Physiological Phenomena

Indicated for · 35

Diagnoses11

Leiomyoma Puberty, Precocious Endometriosis Neoplasms, Muscle Tissue Infertility Prostatic Hyperplasia Neoplasms, Connective and Soft Tissue Genital Neoplasms, Female Genital Neoplasms, Male Genital Diseases, Male Genital Diseases, Female

Condition families24

Endometrial Neoplasms Uterine Neoplasms Ovarian Neoplasms Prostatic Neoplasms Uterine Diseases Ovarian Diseases Adnexal Diseases Endocrine Gland Neoplasms Prostatic Diseases Gonadal Disorders Breast Neoplasms Breast Diseases Urogenital Neoplasms Neoplasms by Histologic Type Genital Diseases Endocrine System Diseases Neoplasms by Site Neoplasms Male Urogenital Diseases Female Urogenital Diseases Skin Diseases Female Urogenital Diseases and Pregnancy Complications Skin and Connective Tissue Diseases Urogenital Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.